News
SAN FRANCISCO, April 21, 2025 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) reported its fourth-quarter 2024 earnings, missing analyst expectations and prompting a ...
LOS ANGELES, April 21, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Maravai LifeSciences Holdings ...
The BCCI has four contract categories: Grade A+ players earn Rs 7 crore, Grade A get Rs 5 crore, Grade B receive Rs 3 crore, and Grade C are paid Rs 1 crore per year. To qualify for a contract, a ...
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Maravai LifeSciences To Contact Him Directly To Discuss Their ...
NEW YORK, NY / ACCESS Newswire / April 19, 2025 / If you suffered a loss on your Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) investment and want to learn about a potential recovery under the ...
CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (1) Maravai lacked adequate internal controls over financial reporting related to revenue ...
or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: A class action securities ...
(MENAFN- GlobeNewsWire - Nasdaq) SAN FRANCISCO, April 16, 2025 (GLOBE NEWSWIRE) -- Shares of Maravai LifeSciences Holdings (NASDAQ: MRVI) fell nearly 6% on March 19, 2025, following revelations ...
MRVI Investors Have Opportunity to Lead Maravai Lifesciences Holdings, Inc. Securities Fraud Lawsuit
Why: Rosen Law Firm, a global investor rights law firm, reminds of purchasers of securities of Maravai Lifesciences Holdings, Inc. (NASDAQ: MRVI) between August 7, 2024 and February 24 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results